Danaher (DHR) revenue tops expectations on strong respiratory testing demand
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- Netflix raises prices in Germany and Austria, Citi comments
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Danaher beats profit estimates on respiratory testing demand
October 24, 2023 7:53 AM EDT(Reuters) - Danaher on Tuesday beat Wall Street estimates for third-quarter profit as strong demand for its diagnostic tests for respiratory diseases helped soften the blow from weaker sales at the healthcare conglomerate's life-sciences unit.
The diagnostics unit, which makes kits, also used for COVID-19 testing, as well as reagents and other tools, reported sales of $2.25 billion, beating the average analyst estimate of $2.12 billion, according to LSEG data.
... MoreDanaher (DHR) Tops Q3 EPS by 25c, Beats on Revenue
October 24, 2023 6:02 AM EDTDanaher (NYSE: DHR) reported Q3 EPS of $2.02, $0.25 better than the analyst estimate of $1.77. Revenue for the quarter came in at $6.9 billion versus the consensus estimate of $6.6 billion.
For earnings history and earnings-related data on Danaher (DHR) click here.
... MoreHere's why these are UBS' most preferred healthcare stocks
October 23, 2023 2:23 PM EDTUBS revealed its most preferred stocks in the US healthcare sector in a note to clients earlier this month.
Analyst Eric Potoker said that while the firm is Neutral on the sector as a whole, there are some names the firm believes has potential upside, with healthcare valuations at a modest discount relative to the broader market.
The... More
Danaher (DHR) October weekly option implied volatility into quarter results
October 23, 2023 10:44 AM EDTDanaher (NYSE: DHR) October weekly call option implied volatility is at 51, November is at 34; compared to its 52-week range of 32 to 35 into the expected release of quarter results before the bell on October 24.
... MoreDanaher (DHR) PT Lowered to $227 at Baird
October 23, 2023 6:35 AM EDTBaird analyst Catherine Schulte lowered the price target on Danaher (NYSE: DHR) to $227.00 (from $270.00) while maintaining a Outperform rating.... More
Danaher (DHR) October weekly 205 straddle into quarter results
October 23, 2023 4:21 AM EDTDanaher (NYSE: DHR) October weekly 205 straddle is priced for a move of 5% into the expected release of quarter results before the bell on October 24.
... More